JP2013523181A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523181A5 JP2013523181A5 JP2013505078A JP2013505078A JP2013523181A5 JP 2013523181 A5 JP2013523181 A5 JP 2013523181A5 JP 2013505078 A JP2013505078 A JP 2013505078A JP 2013505078 A JP2013505078 A JP 2013505078A JP 2013523181 A5 JP2013523181 A5 JP 2013523181A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- cell
- endogenous protein
- human
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 26
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 238000000034 method Methods 0.000 claims 11
- 108010042407 Endonucleases Proteins 0.000 claims 10
- 102000004533 Endonucleases Human genes 0.000 claims 10
- 230000002759 chromosomal effect Effects 0.000 claims 7
- 238000003776 cleavage reaction Methods 0.000 claims 6
- 230000007017 scission Effects 0.000 claims 6
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 238000011144 upstream manufacturing Methods 0.000 claims 4
- NPOAOTPXWNWTSH-UHFFFAOYSA-N 3-hydroxy-3-methylglutaric acid Chemical compound OC(=O)CC(O)(C)CC(O)=O NPOAOTPXWNWTSH-UHFFFAOYSA-N 0.000 claims 2
- 102000007469 Actins Human genes 0.000 claims 2
- 108010085238 Actins Proteins 0.000 claims 2
- 102000009012 HMGA Proteins Human genes 0.000 claims 2
- 108010049069 HMGA Proteins Proteins 0.000 claims 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 108010047294 Lamins Proteins 0.000 claims 2
- 102000006835 Lamins Human genes 0.000 claims 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 2
- 102000004243 Tubulin Human genes 0.000 claims 2
- 108090000704 Tubulin Proteins 0.000 claims 2
- 230000005782 double-strand break Effects 0.000 claims 2
- 210000005053 lamin Anatomy 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32370210P | 2010-04-13 | 2010-04-13 | |
| US32371910P | 2010-04-13 | 2010-04-13 | |
| US32369810P | 2010-04-13 | 2010-04-13 | |
| US61/323,698 | 2010-04-13 | ||
| US61/323,702 | 2010-04-13 | ||
| US61/323,719 | 2010-04-13 | ||
| US36701710P | 2010-07-23 | 2010-07-23 | |
| US61/367,017 | 2010-07-23 | ||
| US39066810P | 2010-10-07 | 2010-10-07 | |
| US61/390,668 | 2010-10-07 | ||
| US40885610P | 2010-11-01 | 2010-11-01 | |
| US61/408,856 | 2010-11-01 | ||
| US201161431957P | 2011-01-12 | 2011-01-12 | |
| US61/431,957 | 2011-01-12 | ||
| PCT/US2011/032218 WO2011130346A1 (en) | 2010-04-13 | 2011-04-13 | Methods for generating endogenously tagged protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523181A JP2013523181A (ja) | 2013-06-17 |
| JP2013523181A5 true JP2013523181A5 (OSRAM) | 2014-05-08 |
| JP5841997B2 JP5841997B2 (ja) | 2016-01-13 |
Family
ID=44799004
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505077A Active JP5841996B2 (ja) | 2010-04-13 | 2011-04-13 | 異種タンパク質を発現するための内因性プロモーターの使用 |
| JP2013505078A Active JP5841997B2 (ja) | 2010-04-13 | 2011-04-13 | 内因性にタグ付けされたタンパク質を生成するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505077A Active JP5841996B2 (ja) | 2010-04-13 | 2011-04-13 | 異種タンパク質を発現するための内因性プロモーターの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US20130065310A1 (OSRAM) |
| EP (2) | EP2558575B1 (OSRAM) |
| JP (2) | JP5841996B2 (OSRAM) |
| KR (2) | KR20130055588A (OSRAM) |
| CN (3) | CN102971421A (OSRAM) |
| BR (1) | BR112012026379A2 (OSRAM) |
| CA (2) | CA2795636C (OSRAM) |
| DK (1) | DK2558575T3 (OSRAM) |
| ES (1) | ES2565216T3 (OSRAM) |
| WO (3) | WO2011130343A1 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101971741B1 (ko) | 2010-07-23 | 2019-08-14 | 시그마-알드리치 컴퍼니., 엘엘씨 | 표적화 엔도뉴클레아제 및 단일-가닥 핵산을 사용하는 게놈 편집 |
| US9012617B2 (en) * | 2011-04-11 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | Detection reagents for tyrosine kinase activity and methods of use thereof |
| CN111893140A (zh) * | 2011-12-05 | 2020-11-06 | 菲克特生物科学股份有限公司 | 用于转染细胞的方法和产品 |
| GB201122458D0 (en) | 2011-12-30 | 2012-02-08 | Univ Wageningen | Modified cascade ribonucleoproteins and uses thereof |
| CN105026422B (zh) | 2012-03-27 | 2019-09-27 | 西安大略大学 | Sh2结构域变体 |
| WO2013158309A2 (en) * | 2012-04-18 | 2013-10-24 | The Board Of Trustees Of The Leland Stanford Junior University | Non-disruptive gene targeting |
| JP6517143B2 (ja) * | 2012-10-23 | 2019-05-22 | ツールゲン インコーポレイテッド | 標的ｄｎａに特異的なガイドｒｎａおよびｃａｓタンパク質コード核酸またはｃａｓタンパク質を含む、標的ｄｎａを切断するための組成物、ならびにその使用 |
| NZ712727A (en) | 2013-03-14 | 2017-05-26 | Caribou Biosciences Inc | Compositions and methods of nucleic acid-targeting nucleic acids |
| KR102736149B1 (ko) | 2014-03-21 | 2024-11-28 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 뉴클레아제 없는 게놈 편집 |
| SI3126381T2 (sl) * | 2014-04-01 | 2022-05-31 | Biontech Cell&Gene Therapies Gmbh | Claudin-6-specifični imunoreceptorji in t-celični epitopi |
| US20180250424A1 (en) | 2014-10-10 | 2018-09-06 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP3215617B1 (en) | 2014-11-07 | 2024-05-08 | Editas Medicine, Inc. | Systems for improving crispr/cas-mediated genome-editing |
| KR20170127015A (ko) * | 2015-03-13 | 2017-11-20 | 유니버시티 오브 매릴랜드, 발티모어 | 만능항체 매개 바이오센서 |
| WO2017053879A1 (en) | 2015-09-24 | 2017-03-30 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| CN115806940A (zh) * | 2015-11-04 | 2023-03-17 | 菲特治疗公司 | 多能细胞的基因组工程改造 |
| CN108495928A (zh) * | 2015-12-23 | 2018-09-04 | 芬兰国家技术研究中心股份公司 | 用于从细胞获得指示剂信号的方法 |
| WO2017165826A1 (en) | 2016-03-25 | 2017-09-28 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| US11236313B2 (en) | 2016-04-13 | 2022-02-01 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
| CN106800602B (zh) * | 2017-01-22 | 2020-05-01 | 中国科学院生物物理研究所 | 一种可视化标记基因组位点的方法 |
| WO2018148603A1 (en) * | 2017-02-09 | 2018-08-16 | Allen Institute | Genetically-tagged stem cell lines and methods of use |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US11932858B2 (en) | 2017-12-14 | 2024-03-19 | Donald Danforth Plant Science Center | Homologous recombination via transcriptional activation |
| EP3788150A4 (en) * | 2018-05-04 | 2022-01-26 | Sigma-Aldrich Co. LLC | PRODUCTION OF RECOMBINANT PROTEINS WITH REDUCED LEVELS OF HOST CELL PROTEINS |
| WO2020141109A1 (en) * | 2018-12-30 | 2020-07-09 | F. Hoffmann-La Roche Ag | Method for the selection of cells based on crispr/cas-controlled integration of a detectable tag to a target protein |
| WO2021055372A1 (en) * | 2019-09-16 | 2021-03-25 | Fred Hutchinson Cancer Research Center | Chimeric receptor proteins and uses thereof |
| CN113684228B (zh) * | 2021-10-26 | 2022-03-11 | 天九再生医学(天津)科技有限公司 | 利用内参快速准确表征蛋白质相对丰度的方法 |
| CN114703174B (zh) * | 2022-04-12 | 2023-10-24 | 中国科学院海洋研究所 | 快速获得基因型和表型突变的CRISPR/Cas9基因敲除方法及应用 |
| CN115948401A (zh) * | 2022-12-19 | 2023-04-11 | 中国科学技术大学 | 一种多靶点rna靶向敲低系统及应用 |
| CN120177781B (zh) * | 2025-05-22 | 2025-08-12 | 南京师范大学 | 生物传感器及其应用和高通量筛选花姜酮生产菌的方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192772B1 (en) * | 1988-08-31 | 2007-03-20 | The University Of Florida Research Foundations, Inc. | Recombinant cells that highly express chromosomally-integrated heterologous gene |
| US7090976B2 (en) * | 1999-11-10 | 2006-08-15 | Rigel Pharmaceuticals, Inc. | Methods and compositions comprising Renilla GFP |
| US6495664B1 (en) * | 1998-07-24 | 2002-12-17 | Aurora Biosciences Corporation | Fluorescent protein sensors of post-translational modifications |
| US6534261B1 (en) * | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6710170B2 (en) * | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US7125660B2 (en) * | 2000-09-13 | 2006-10-24 | Archemix Corp. | Nucleic acid sensor molecules and methods of using same |
| AU2002327730A1 (en) * | 2001-09-26 | 2003-04-07 | University Of North Carolina At Chapel Hill | Variants of alpha-fetoprotein coding and expression sequences |
| WO2005014791A2 (en) * | 2003-08-08 | 2005-02-17 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7402436B2 (en) * | 2004-05-03 | 2008-07-22 | City Of Hope | Lentiviral vectors for site-specific gene insertion |
| WO2006017751A2 (en) * | 2004-08-02 | 2006-02-16 | Cellumen, Inc. | Methods for the detection of molecular interactions within cells |
| CA2579677A1 (en) * | 2004-09-16 | 2006-03-30 | Sangamo Biosciences, Inc. | Compositions and methods for protein production |
| US20060171929A1 (en) * | 2005-01-31 | 2006-08-03 | The University Of Washington | Regulation of dendritic cell functions by the DCAL-2 receptor |
| US20060199226A1 (en) * | 2005-03-02 | 2006-09-07 | Schiffer Hans H | Functional bioluminescence energy resonance transfer (BRET) assay to screen, identify and characterize receptor tyrosine kinase ligands |
| EP1869206A4 (en) * | 2005-03-02 | 2011-08-10 | Einstein Coll Med | ENZYME SENSORS WITH ENVIRONMENTAL SENSITIVE OR FLUORESCENT LABELS AND APPLICATIONS THEREOF |
| US8114964B2 (en) * | 2005-05-19 | 2012-02-14 | Centocor, Inc. | Anti-MCP-1 antibodies, compositions, methods and uses |
| WO2007013979A2 (en) * | 2005-07-20 | 2007-02-01 | Invitrogen Corporation | Methods for increasing efficiency of homologous recombination |
| US20090263900A1 (en) * | 2008-04-14 | 2009-10-22 | Sangamo Biosciences, Inc. | Linear donor constructs for targeted integration |
| US20080305519A1 (en) * | 2006-02-23 | 2008-12-11 | Qing Lin | Biochemical method for specific protein labeling |
| US20100009352A1 (en) * | 2006-05-24 | 2010-01-14 | Gough Albert H | Method for Modeling a Disease |
| WO2009054985A1 (en) * | 2007-10-25 | 2009-04-30 | Sangamo Biosciences, Inc. | Methods and compositions for targeted integration |
| EP2789691B1 (en) * | 2008-08-22 | 2018-08-08 | Sangamo Therapeutics, Inc. | Methods and compositions for targeted single-stranded cleavage and targeted integration |
-
2011
- 2011-04-13 CN CN2011800291603A patent/CN102971421A/zh active Pending
- 2011-04-13 JP JP2013505077A patent/JP5841996B2/ja active Active
- 2011-04-13 EP EP11769489.3A patent/EP2558575B1/en active Active
- 2011-04-13 US US13/641,036 patent/US20130065310A1/en not_active Abandoned
- 2011-04-13 JP JP2013505078A patent/JP5841997B2/ja active Active
- 2011-04-13 CN CN201180029129.XA patent/CN102959078B/zh active Active
- 2011-04-13 BR BR112012026379A patent/BR112012026379A2/pt not_active Application Discontinuation
- 2011-04-13 WO PCT/US2011/032214 patent/WO2011130343A1/en not_active Ceased
- 2011-04-13 ES ES11769489.3T patent/ES2565216T3/es active Active
- 2011-04-13 CA CA2795636A patent/CA2795636C/en active Active
- 2011-04-13 EP EP11769488.5A patent/EP2558574B1/en active Active
- 2011-04-13 US US13/641,050 patent/US20130059362A1/en not_active Abandoned
- 2011-04-13 WO PCT/US2011/032216 patent/WO2011130345A1/en not_active Ceased
- 2011-04-13 CN CN201711044283.XA patent/CN107805278A/zh active Pending
- 2011-04-13 CA CA2795643A patent/CA2795643C/en active Active
- 2011-04-13 DK DK11769489.3T patent/DK2558575T3/en active
- 2011-04-13 KR KR1020127028401A patent/KR20130055588A/ko not_active Ceased
- 2011-04-13 KR KR1020127028946A patent/KR20130054955A/ko not_active Ceased
- 2011-04-13 WO PCT/US2011/032218 patent/WO2011130346A1/en not_active Ceased
- 2011-04-13 US US13/641,023 patent/US20130059388A1/en not_active Abandoned
-
2017
- 2017-05-31 US US15/609,983 patent/US20180105564A1/en not_active Abandoned
- 2017-07-19 US US15/654,419 patent/US20180134759A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523181A5 (OSRAM) | ||
| MY193112A (en) | Anti pd-1 and anti-lag3 antibodies for cancer treatment | |
| JP2013523180A5 (OSRAM) | ||
| SA520411173B1 (ar) | Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137 | |
| EP4434997A3 (en) | Delivery of negatively charged proteins using cationic lipids | |
| AR106752A1 (es) | Proteínas de unión a pd1 / ctla4 | |
| EP4269577A3 (en) | Nucleobase editors and uses thereof | |
| UA112985C2 (uk) | Одноланцюговий поліпептидний гібридний білок | |
| WO2020198509A3 (en) | Modified oligonucleotides with increased stability | |
| MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
| WO2018073393A3 (en) | Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy | |
| EP3564259A3 (en) | Recognition tags for tgase-mediated conjugation | |
| WO2014202616A3 (en) | Rasamsonia gene and use thereof | |
| NZ751946A (en) | Rna-guided nucleic acid modifying enzymes and methods of use thereof | |
| FI4269430T3 (fi) | Ei-ihmiseläimiä, joilla on humanisoitu signaalin säätelyproteiinigeeni | |
| WO2017011773A3 (en) | Codon-optimized nucleic acids encoding antibodies | |
| FI3604532T3 (fi) | Uusia crispr-entsyymejä ja järjestelmiä | |
| NZ713602A (en) | Method for refining protein including self-cutting cassette and use thereof | |
| ZA201703241B (en) | Anti-c5 antibodies and methods of use | |
| WO2014172470A3 (en) | Methods of mutating, modifying or modulating nucleic acid in a cell or nonhuman mammal | |
| WO2009111067A3 (en) | Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation | |
| EP4349854A3 (en) | Pd1-cd28 fusion proteins and their use in medicine | |
| WO2012019168A3 (en) | Engineered nucleic acids and methods of use thereof | |
| BR112015022978A2 (pt) | agente de ligação biespecífico, seu método de produção composição farmacêutica, proteína de fusão, uso, sequência de ácido nucleico, vetor, célula hospedeira, método de matar células tumorais e de inibir o crescimento tumoral | |
| MX2022016002A (es) | Construcciones de anticuerpos de adn y metodo para utilizarlas. |